Form 4 for CYTK CYTOKINETICS INC
Accepted 2023-10-03 00:00:00 ET · period of report 2023-10-02 · accession 0001127602-23-025181 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-03 | 2023-10-02 | CYTK | HENDERSON JOHN T | Dir | A - Grant | $27.88 | +762 | 31.8K | +2% | +$21.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-02 | A | A | 762 | $27.88 | 31,818 | D | — | — | (F1) Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $27.88, representing the closing stock price of the Issuer's common stock on October 2, 2023. |